Skip to content

Inspection Record

PCAS Finland Oy — FDA 483 Findings

US FDAInspected 2024-06-07Published 2026-10-26 3 findingsOther quality systemEquipment and facility

Inspectors Lewis K Antwi · Gene D ArcyThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Your firm has not investigated unknown (including one known as indicated by an in-house analytical method.

2Equipment and facility

Your firm has not repaired and maintained manufacturing spaces & equipment in which bioburden- controlled manufacturing processes are conducted for API On 05 JUN 2024, the following conditions were observed: a)Two holes (apparently about the diameter of a U.S.

3Equipment and facility

Failure to maintain equipment used for the manufacturing of API.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

PCAS Finland Oy company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.